Update of faecal markers of inflammation in children with cystic fibrosis

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Lee, Jung M ^a   Leach, Steven T ^a   Katz, Tamarah ^b   Day, Andrew S ^c   Jaffe, Adam ^a   Ooi, Chee Y ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CALGRANULIN; EOSINOPHIL CATIONIC PROTEIN; FECAL INFLAMMATORY MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 8; LACTOFERRIN; LEUKOCYTE ELASTASE; PROTEIN S 100; PROTEIN S100 A12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; S100A12 PROTEIN, HUMAN;

CYSTIC FIBROSIS; ENTERITIS; HUMAN; LUNG FUNCTION; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; SURVIVAL; CHEMISTRY; FECES; IMMUNOLOGY; INFLAMMATION; METABOLISM;

BIOLOGICAL MARKERS; CYSTIC FIBROSIS; FECES; HUMANS; INFLAMMATION; LEUKOCYTE L1 ANTIGEN COMPLEX; S100 PROTEINS;

EID: 84867758702     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/948367     Document Type: Review

References (38)

1. Yankaskas J. R., Marshall B. C., Sufian B., Simon R. H., Rodman D., Cystic fibrosis adult care: consensus conference report. Chest 2004 125 1, supplement 1S 39S 2-s2.0-0347301908 (Pubitemid 38096189)
2. Renaud W., Merten M., Figarella C., Increased coexpression of CFTR and S100 calcium binding proteins MRP8 and MRP14 mRNAs in cystic fibrosis human tracheal gland cells. Biochemical and Biophysical Research Communications 1994 201 3 1518 1525 2-s2.0-0027999172 10.1006/bbrc.1994.1876
3. Riordan J. R., Rommens J. M., Kerem B. S., Alon N., Rozmahel R., Grzelczak Z., Zielinski J., Lok S., Plavsic N., Chou J. L., Drumm M. L., Iannuzzi M. C., Collins F. S., Tsui L. C., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989 245 4922 1066 1073 2-s2.0-0024424270 (Pubitemid 19231814)
4. Quinton P. M., Chloride impermeability in cystic fibrosis. Nature 1983 301 5899 421 422 2-s2.0-0020700816 (Pubitemid 13160555)
5. Reddy M. M., Quinton P. M., Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances. Journal of the Pancreas 2001 2 4 212 218 2-s2.0-0035412020 (Pubitemid 38963853)
6. Corey M., McLaughlin F. J., Williams M., Levison H., A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. Journal of Clinical Epidemiology 1988 41 6 583 591 2-s2.0-0023923679
7. Lai H. C., Corey M., Fitzsimmons S., Kosorok M. R., Farrell P. M., Comparison of growth status of patients with cystic fibrosis between the United States and Canada. American Journal of Clinical Nutrition 1999 69 3 531 538 2-s2.0-0032965421 (Pubitemid 29104577)
8. Corey M., Gaskin K., Durie P., Levison H., Forstner G., Improved prognosis in CF patients with normal fat absorption. Journal of Pediatric Gastroenterology and Nutrition 1984 3 supplement 1 S99 S105 2-s2.0-0021749217 (Pubitemid 15218800)
9. Pencharz P. B., Durie P. R., Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clinical Nutrition 2000 19 6 387 394 2-s2.0-0033669816 10.1054/clnu.1999.0079
10. Norkina O., Burnett T. G., De Lisle R. C., Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infection and Immunity 2004 72 10 6040 6049 2-s2.0-4644246657 10.1128/IAI.72.10.6040-6049.2004 (Pubitemid 39303719)
11. De Lisle R. C., Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. American Journal of Physiology 2007 293 1 G104 G111 2-s2.0-34547094857 10.1152/ajpgi.00548.2006 (Pubitemid 47105181)
12. Ballinger A. B., Camacho-Hübner C., Croft N. M., Growth failure and intestinal inflammation. QJM 2001 94 3 121 125 2-s2.0-0035077955 (Pubitemid 32241999)
13. Smyth R. L., Croft N. M., O'Hea U., Marshall T. G., Ferguson A., Intestinal inflammation in cystic fibrosis. Archives of Disease in Childhood 2000 82 5 394 399 2-s2.0-0034025852 10.1136/adc.82.5.394 (Pubitemid 30307771)
14. Raia V., Maiuri L., de Ritis G., De Vizia B., Vacca L., Conte R., Auricchio S., Londei M., Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatric Research 2000 47 3 344 350 2-s2.0-0034000370 (Pubitemid 30127040)
15. Bruzzese E., Raia V., Gaudiello G., Polito G., Buccigrossi V., Formicola V., Guarino A., Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Alimentary Pharmacology and Therapeutics 2004 20 7 813 819 2-s2.0-4844226186 10.1111/j.1365-2036.2004.02174. x (Pubitemid 39319237)
16. Werlin S. L., Benuri-Silbiger I., Kerem E., Adler S. N., Goldin E., Zimmerman J., Malka N., Cohen L., Armoni S., Yatzkan-Israelit Y., Bergwerk A., Aviram M., Bentur L., Mussaffi H., Bjarnasson I., Wilschanski M., Evidence of intestinal inflammation in patients with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition 2010 51 3 304 308 2-s2.0-77956439080 10.1097/MPG.0b013e3181d1b013
17. Bruzzese E., Raia V., Spagnuolo M. I., Volpicelli M., De Marco G., Maiuri L., Guarino A., Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clinical Nutrition 2007 26 3 322 328 2-s2.0-34248588695 10.1016/j.clnu.2007.01.004 (Pubitemid 46760477)
18. Weiss B., Bujanover Y., Yahav Y., Vilozni D., Fireman E., Efrati O., Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatric Pulmonology 2010 45 6 536 540 2-s2.0-77953320256 10.1002/ppul.21138
19. Tibble J. A., Sigthorsson G., Bridger S., Fagerhol M. K., Bjarnason I., Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000 119 1 15 22 2-s2.0-0034234796 (Pubitemid 30452574)
20. Golden B. E., Clohessy P. A., Russell G., Fagerhol M. K., Calprotectin as a marker of inflammation in cystic fibrosis. Archives of Disease in Childhood 1996 74 2 136 139 2-s2.0-0030020437 (Pubitemid 26057695)
21. Foell D., Seeliger S., Vogl T., Koch H. G., Maschek H., Harms E., Sorg C., Roth J., Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 2003 58 7 613 617 2-s2.0-0038015368 10.1136/thorax.58.7.613 (Pubitemid 36808133)
22. Donato R., Intracellular and extracellular roles of S100 proteins. Microscopy Research and Technique 2003 60 6 540 551 2-s2.0-0142229704
23. Foell D., Wittkowski H., Vogl T., Roth J., S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. Journal of Leukocyte Biology 2007 81 1 28 37 2-s2.0-33845868493 10.1189/jlb.0306170 (Pubitemid 46021248)
24. M N. S., The S100 family of multipurpose calcium-binding proteins. Journal of Cutaneous Pathology 1998 25 10 521 529 2-s2.0-0031744189
25. Foell D., Wittkowski H., Roth J., Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut 2009 58 6 859 868 2-s2.0-66649100476 10.1136/gut.2008.170019
26. Brandtzaeg P., Gabrielsen T. O., Dale I., Muller F., Steinbakk M., Fagerhol M. K., The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Advances in Experimental Medicine and Biology 1995 371 201 206 2-s2.0-0029100017
27. Sohnle P. G., Hunter M. J., Hahn B., Chazin W. J., Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). Journal of Infectious Diseases 2000 182 4 1272 1275 2-s2.0-0033796465 10.1086/315810
28. Tibble J., Teahon K., Thjodleifsson B., A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000 47 506 513
29. Bunn S. K., Bisset W. M., Main M. J., Golden B. E., Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2001 32 171 177 (Pubitemid 32280632)
30. Bunn S. K., Bisset W. M., Main M. J. C., Gray E. S., Olson S., Golden B. E., Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2001 33 1 14 22 2-s2.0-0034906225 10.1097/00005176-200107000-00003 (Pubitemid 32706118)
31. Sidler M. A., Leach S. T., Day A. S., Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflammatory Bowel Diseases 2008 14 3 359 366 2-s2.0-41149109122 10.1002/ibd.20336 (Pubitemid 351441325)
32. von Roon A. C., Karamountzos L., Purkayastha S., Reese G. E., Darzi A. W., Teare J. P., Paraskeva P., Tekkis P. P., Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. American Journal of Gastroenterology 2007 102 4 803 813 2-s2.0-33947683926 10.1111/j.1572-0241.2007.01126.x (Pubitemid 46496634)
33. Costa F., Mumolo M. G., Bellini M., Romano M. R., Ceccarelli L., Arpe P., Sterpi C., Marchi S., Maltinti G., Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Digestive and Liver Disease 2003 35 9 642 647 2-s2.0-1542394043 10.1016/S1590-8658(03)00381-5 (Pubitemid 41110875)
34. Golden B. E., Clohessy P. A., Russell G., Fagerhol M. K., Calprotectin as a marker of inflammation in cystic fibrosis. Archives of Disease in Childhood 1996 74 2 136 139 2-s2.0-0030020437 (Pubitemid 26057695)
35. Thomas G. R., Costelloe E. A., Lunn D. P., Stacey K. J., Delaney S. J., Passey R., McGlinn E. C., McMorran B. J., Ahadizadeh A., Geczy C. L., Wainwright B. J., Hume D. A., G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages. Journal of Immunology 2000 164 7 3870 3877 2-s2.0-17344381330 (Pubitemid 30169846)
36. Hofmann M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M. F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A. M., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999 97 7 889 901 2-s2.0-0033603241 10.1016/S0092-8674(00) 80801-6 (Pubitemid 29375048)
37. Ooi C. Y., Lee J. M., Leach S., Katz T., Day A. S., Jaffe A., Intestinal inflammation in CF: stool markers and correlation with pancreatic enzymes. Journal of Cystic Fibrosis 2012 11, supplement 1 S114
38. de Jong N. S. H., Leach S. T., Day A. S., Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. Inflammatory Bowel Diseases 2006 12 7 566 572 2-s2.0-33745524590 10.1097/01.ibd.0000227626.72271.91 (Pubitemid 43977737)